Increased Serum Prostate-Specific Antigen in a Man and a Woman with Hepatitis A
- 18 December 1997
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 337 (25) , 1849-1850
- https://doi.org/10.1056/nejm199712183372515
Abstract
Although prostate-specific antigen (PSA) was originally thought to be a prostate-epithelium–specific marker,1 it has now been described in other tissues and body fluids, including liver, colon, lung, kidney, breast, ovarian, and parotid tumors; normal breast; salivary gland and endometrium; breast milk; and amniotic fluid.2-4 Likewise, the prostate-specific membrane antigen is a novel biomarker that can be detected in a variety of healthy and malignant non-prostate tissues.3,5 A quantitative assessment of the tissue expression of this glycoprotein seems to indicate that high levels of prostate-specific membrane antigen transcripts are present in normal liver, brain, and small intestine and that such tissue levels are only about one fifth of those in prostate tissue.5 We describe a man and woman in whom increased serum PSA levels were detected during acute viral hepatitis.Keywords
This publication has 4 references indexed in Scilit:
- Prostate-specific membrane antigen in breast carcinomaThe Lancet, 1997
- Detection and characterization of the prostate‐specific membrane antigen (PSMA) in tissue extracts and body fluidsInternational Journal of Cancer, 1995
- Prostate-specific antigen and lack of specificity for prostate cellsThe Lancet, 1995
- Prostate Cancer Screening: What We Know and What We Need To KnowAnnals of Internal Medicine, 1993